Drug recall D-0615-2021
Product
NovoLog FlexPen (insulin aspart) Injection, 100 units/mL, 3 mL Prefilled Insulin Syringe pen, Sample. Not for Resale, Rx Only, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-6339-90 (Pen), NDC 0169-6339-98 (Kit)
Reason for recall
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Lots and codes
KS6BS11, Exp 11/30/2021
Recall details
- Recalling firm
- Novo Nordisk Inc, Plainsboro, NJ
- Quantity
- N/A
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 22, 2021
- Terminated
- December 9, 2022
Related products
- Insulin Diluting Medium for NovoLog – drug information
- NDC 0169-2100 Novolog · Insulin Aspart 100 [iU]/mL · Novo Nordisk
- NDC 0169-2101 Novolog · Insulin Aspart 100 [iU]/mL · Novo Nordisk
- NDC 0169-7501 Novolog · Insulin Aspart 100 [iU]/mL · Novo Nordisk
- NDC 0169-2001 Insulin Diluting Medium for NovoLog · Water 1 mL/mL · Novo Nordisk
- NDC 0169-6338 Novolog · Insulin Aspart 100 [iU]/mL · Novo Nordisk
- NDC 0169-6339 Novolog · Insulin Aspart 100 [iU]/mL · Novo Nordisk
- NDC 0169-3303 Novolog · Insulin Aspart 100 [iU]/mL · Novo Nordisk